Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT). Prognostic significance of raised serum tumor markers (STM) after 2 cycles of chemotherapy in men with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback